Cibc Asset Management Inc Charles River Laboratories International, Inc. Transaction History

Cibc Asset Management Inc

$28 Billion
Q4 2024

A detailed history of Cibc Asset Management Inc transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Cibc Asset Management Inc holds 7,302 shares of CRL stock, worth $1.19 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

7,302

Previous 7,531 3.04%

Holding current value

$1.19 Million

Previous $1.48 Million 9.17%

% of portfolio

0.0%

Previous 0.01%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 31, 2025	SELL	$178.58 - $220.69 $40,894 - $50,538	-229 Reduced 3.04%	7,302 $1.35 Million
Q3 2024 Nov 06, 2024	BUY	$187.96 - $245.29 $111,836 - $145,947	595 Added 8.58%	7,531 $1.48 Million
Q2 2024 Aug 01, 2024	SELL	$206.39 - $268.73 $61,710 - $80,350	-299 Reduced 4.13%	6,936 $1.43 Million
Q1 2024 May 09, 2024	BUY	$203.52 - $273.43 $44,163 - $59,334	217 Added 3.09%	7,235 $1.96 Million
Q4 2023 Feb 13, 2024	SELL	$164.52 - $238.84 $34,055 - $49,439	-207 Reduced 2.87%	7,018 $1.66 Million
Q3 2023 Oct 30, 2023	SELL	$194.44 - $217.61 $12,833 - $14,362	-66 Reduced 0.91%	7,225 $1.42 Million
Q2 2023 Aug 14, 2023	SELL	$183.71 - $210.25 $12,492 - $14,297	-68 Reduced 0.92%	7,291 $1.53 Million
Q1 2023 May 12, 2023	BUY	$191.89 - $259.92 $44,518 - $60,301	232 Added 3.26%	7,359 $1.49 Million
Q4 2022 Feb 13, 2023	BUY	$197.11 - $250.07 $81,209 - $103,028	412 Added 6.14%	7,127 $1.55 Million
Q3 2022 Nov 03, 2022	BUY	$182.44 - $250.54 $112,383 - $154,332	616 Added 10.1%	6,715 $1.32 Million
Q2 2022 Aug 09, 2022	BUY	$204.13 - $302.4 $268,635 - $397,958	1,316 Added 27.51%	6,099 $1.31 Million
Q1 2022 May 06, 2022	BUY	$255.51 - $362.11 $12,008 - $17,019	47 Added 0.99%	4,783 $1.36 Million
Q4 2021 Feb 08, 2022	BUY	$351.38 - $448.68 $106,116 - $135,501	302 Added 6.81%	4,736 $1.78 Million
Q3 2021 Nov 09, 2021	BUY	$372.64 - $458.3 $57,759 - $71,036	155 Added 3.62%	4,434 $1.83 Million
Q2 2021 Aug 16, 2021	BUY	$294.17 - $371.65 $719,833 - $909,427	2,447 Added 133.57%	4,279 $1.58 Million
Q1 2021 May 14, 2021	SELL	$249.67 - $299.48 $25,216 - $30,247	-101 Reduced 5.23%	1,832 $531,000
Q3 2020 Nov 05, 2020	BUY	$175.56 - $226.45 $8,426 - $10,869	48 Added 2.55%	1,933 $438,000
Q4 2019 Feb 14, 2020	BUY	$126.05 - $152.76 $25,840 - $31,315	205 Added 12.2%	1,885 $288,000
Q1 2019 May 06, 2019	BUY	$104.82 - $146.73 $176,097 - $246,506	1,680 New	1,680 $244,000
Q4 2018 Feb 12, 2019	SELL	$105.09 - $137.23 $176,551 - $230,546	-1,680 Closed	0 $0
Q3 2018 Nov 02, 2018	BUY	$112.11 - $134.54 $188,344 - $226,027	1,680 New	1,680 $226,000

Others Institutions Holding CRL

# of Institutions

708

Shares Held

53.9M

Call Options Held

122K

Put Options Held

239K

View Full List

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.

Ticker CRL
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 50,863,300
Market Cap $8.29B
Description
Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...

More about CRL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cibc Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Cibc Asset Management Inc with notifications on news.

Account

Cibc Asset Management Inc Charles River Laboratories International, Inc. Transaction History